Laserfiche WebLink
California Standards <br />Federal Primary <br />Standards <br />0.09 ppm/1-hour <br />0.07 ppm/8-hour 0.070 ppm/8-hour <br />(a) Decline in pulmonary function and localized lung edema in humans and animals; (b) Risk <br />to public health implied by alterations in pulmonary morphology and host defense in <br />animals; (c) Increased mortality risk; (d) Risk to public health implied by altered connective <br />tissue metabolism and altered pulmonary morphology in animals after long-term exposures <br />and pulmonary function decrements in chronically exposed humans; (e) Vegetation <br />damage; and (f) Property damage. <br />20.0 ppm/1-hour <br />9.0 ppm/8-hour <br />35.0 ppm/1-hour <br />9.0 ppm/8-hour <br />(a) Aggravation of angina pectoris and other aspects of coronary heart disease; (b) <br />Decreased exercise tolerance in persons with peripheral vascular disease and lung disease; <br />(c) Impairment of central nervous system functions; and (d) Possible increased risk to <br />fetuses. <br />0.18 ppm/1-hour <br />0.03 ppm/annual <br />100 ppb/1-hour <br />0.053 ppm/annual <br />(a) Potential to aggravate chronic respiratory disease and respiratory symptoms in sensitive <br />groups; (b) Risk to public health implied by pulmonary and extra-pulmonary biochemical <br />and cellular changes and pulmonary structural changes; and (c) Contribution to <br />atmospheric discoloration. <br />0.25 ppm/1-hour <br />0.04 ppm/24-hour <br />75 ppb/1-hour <br />0.14 ppm/annual <br />(a) Bronchoconstriction accompanied by symptoms which may include wheezing, <br />shortness of breath and chest tightness, during exercise or physical activity in persons with <br />asthma. <br />50 µg/m3/24-hour <br />20 µg/m3/annual 150 µg/m3/24-hour <br />12 µg/m3 / annual 35 µg/m3/24-hour <br />12 µg/m3/annual <br />25 µg/m3/24-hour No Federal Standards <br />(a) Decrease in ventilatory function; (b) Aggravation of asthmatic symptoms; (c ) <br />Aggravation of cardio-pulmonary disease; (d) Vegetation damage; (e) Degradation of <br />visibility; (f) property damage. <br />1.5 µg/m3/30-day 0.15 µg/m3/3-month <br />rolling (a) Learning disabilities; (b) Impairment of blood formation and nerve conduction. <br />Extinction coefficient <br />of 0.23 per kilometer- <br />visibility of 10 miles or <br />more due to particles <br />when humidity is less <br />than 70 percent. <br />No Federal Standards Visibility impairment on days when relative humidity is less than 70 percent. <br />Source: https://ww2.arb.ca.gov/sites/default/files/2020-07/aaqs2.pdf <br />Table 2 <br />Visibility <br />Reducing <br />Particles <br />Concentration / Averaging Time <br />Most Relevant Effects <br />(a) Exacerbation of symptoms in sensitive patients with respiratory or cardiovascular <br />disease; (b) Declines in pulmonary function growth in children; (c) Increased risk of <br />premature death from heart or lung diseases in elderly. <br />State and Federal Criteria Pollutant Standards <br />Air Pollutant <br />Ozone (O3) <br />Carbon <br />Monoxide <br />(CO) <br />Nitrogen <br />Dioxide (NO2) <br />Sulfur Dioxide <br />(SO2) <br />Suspended <br />Particulate <br />Matter (PM10) <br />Suspended <br />Particulate <br />Matter (PM2.5) <br />Sulfates <br />Lead <br />Cabrillo at First Mixed-Use Residential Project <br />Air Quality, Global Climate Change, HRA and Energy Impact Analysis <br />19386196/27/2022 <br />Planning Commission 2 –72